Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 


Upcoming Unit Investment Trust Deposits
Portfolio Name Ticker Initial Offer Date Cash CUSIP(s) Reinvest CUSIP(s) Term
S&P International Dividend Aristocrats, 3rd Qtr 2020 FGSZEX 7/7/2020
30314A840
30314A865 (Fee)
30314A857
30314A873 (Fee)
15 Month
Diversified Equity Strategic Allocation, 3rd Qtr 2020 FDTSGX 7/9/2020
30314P102
30314P128 (Fee)
30314P110
30314P136 (Fee)
15 Month
Dow® Target 10, July 2020 FHVYNX 7/10/2020
30314H829
30314H845 (Fee)
30314H837
30314H852 (Fee)
13 Month
Dow® Target 5, 3rd Qtr 2020 FOXLSX 7/10/2020
30314P466
30314P482 (Fee)
30314P474
30314P490 (Fee)
15 Month
Dow® Target Dividend, 3rd Qtr 2020 FLEWOX 7/10/2020
30314P508
30314P524 (Fee)
30314P516
30314P532 (Fee)
15 Month
Global Target 15, 3rd Qtr 2020 FOEDMX 7/10/2020
30314P540
30314P565 (Fee)
30314P557
30314P573 (Fee)
15 Month
Income Allocation Closed-End, 3rd Qtr 2020 FIYXWX 7/10/2020
30314H787
30314H803 (Fee)
30314H795
30314H811 (Fee)
15 Month
S&P Dividend Aristocrats Target 25, 3rd Qtr 2020 FLONRX 7/10/2020
30314P581
30314P607 (Fee)
30314P599
30314P615 (Fee)
15 Month
S&P Target 24, 3rd Qtr 2020 FNKVGX 7/10/2020
30314P623
30314P649 (Fee)
30314P631
30314P656 (Fee)
15 Month
S&P Target SMid 60, 3rd Qtr 2020 FMHVXX 7/10/2020
30314Q183
30314Q209 (Fee)
30314Q191
30314Q217 (Fee)
15 Month
Target Diversified Dividend, 3rd Qtr 2020 FMRNAX 7/10/2020
30314P664
30314P680 (Fee)
30314P672
30314P698 (Fee)
15 Month
Target Diversified Global Allocation, 3rd Qtr 2020 FIPGTX 7/10/2020
30314P144
30314P169 (Fee)
30314P151
30314P177 (Fee)
15 Month
Target Dividend Blend, 3rd Qtr 2020 FJIOZX 7/10/2020
30314P383
30314P409 (Fee)
30314P391
30314P417 (Fee)
15 Month
Target Dividend Double Play, 3rd Qtr 2020 FJSGCX 7/10/2020
30314P300
30314P326 (Fee)
30314P318
30314P334 (Fee)
15 Month
Target Dividend Triple Play, 3rd Qtr 2020 FBXKRX 7/10/2020
30314P342
30314P367 (Fee)
30314P359
30314P375 (Fee)
15 Month
Target Double Play, 3rd Qtr 2020 FKVFLX 7/10/2020
30314P706
30314P722 (Fee)
30314P714
30314P730 (Fee)
15 Month
Target Focus Four, 3rd Qtr 2020 FQALBX 7/10/2020
30314Q225
30314Q241 (Fee)
30314Q233
30314Q258 (Fee)
15 Month
Target Global Dividend Leaders, 3rd Qtr 2020 FNUMJX 7/10/2020
30314P748
30314P763 (Fee)
30314P755
30314P771 (Fee)
15 Month
Target Growth, 3rd Qtr 2020 FPHCVX 7/10/2020
30314Q266
30314Q282 (Fee)
30314Q274
30314Q290 (Fee)
15 Month
Target High Quality Dividend, 3rd Qtr 2020 FIFPQX 7/10/2020
30314P425
30314P441 (Fee)
30314P433
30314P458 (Fee)
15 Month
Target Triad, 3rd Qtr 2020 FONUPX 7/10/2020
30314Q308
30314Q324 (Fee)
30314Q316
30314Q332 (Fee)
15 Month
Target VIP, 3rd Qtr 2020 FLYEUX 7/10/2020
30314Q340
30314Q365 (Fee)
30314Q357
30314Q373 (Fee)
15 Month
Value Line® Target 25, 3rd Qtr 2020 FPQTYX 7/10/2020
30314P789
30314P805 (Fee)
30314P797
30314P813 (Fee)
15 Month
Value Line® Target Safety 30, 3rs Qtr 2020 FKBXFX 7/10/2020
30314P185
30314P201 (Fee)
30314P193
30314P219 (Fee)
15 Month
Balanced Income Select, 94 FRDKKX 7/13/2020
30314X386
30314X402 (Fee)
30314X394
30314X410 (Fee)
2 Year
Discount Opportunity Closed-End, 11 FUMILX 7/13/2020
30314U473
30314U499 (Fee)
30314U481
30314U507 (Fee)
2 Year
Pharmaceutical Select, 41 FTTAFX 7/13/2020
30314U515
30314U531 (Fee)
30314U523
30314U549 (Fee)
2 Year
40/60 Strategic Allocation, 3rd Qtr 2020 FQTTHX 7/14/2020
30314T260
30314T286 (Fee)
30314T278
30314T294 (Fee)
15 Month
60/40 Strategic Allocation, 3rd Qtr 2020 FUVZOX 7/14/2020
30314T302
30314T328 (Fee)
30314T310
30314T336 (Fee)
15 Month
75/25 Strategic Allocation, 3rd Qtr 2020 FRWSQX 7/14/2020
30314T344
30314T369 (Fee)
30314T351
30314T377 (Fee)
15 Month
Diversified Fixed Income ETF, 44 FQKCEX 7/14/2020
30314T385
30314T401 (Fee)
30314T393
30314T419 (Fee)
15 Month
Cboe Vest Large Cap Deep Buffered, 5 FKLOIX 7/15/2020
30314U598
30314U606 (Fee)
2 Year
Content Leaders, 18 FVPHUX 7/16/2020
30314U267
30314U283 (Fee)
30314U275
30314U291 (Fee)
15 Month
High-Yield Income Closed-End, 90 FSQAWX 7/16/2020
30314X741
30314X766 (Fee)
30314X758
30314X774 (Fee)
2 Year
Tax Exempt Municipal Income, 312 FCQSXX 7/16/2020
33741B647
33741B654 (Wrap)
TBD
High Dividend Equity, 45 FRNBNX 7/17/2020
30314U358
30314U374 (Fee)
30314U366
30314U382 (Fee)
2 Year
Market Strength Allocation Opportunity, 14 FSGJTX 7/17/2020
30314U739
30314U754 (Fee)
30314U747
30314U762 (Fee)
15 Month
Market Strength Allocation Select, 41 FSZRZX 7/17/2020
30314U697
30314U713 (Fee)
30314U705
30314U721 (Fee)
2 Year
Technology Dividend, 35 FVFQRX 7/17/2020
30314U655
30314U671 (Fee)
30314U663
30314U689 (Fee)
2 Year
American Recovery, 2 ------- 7/20/2020
30314U770
30314U796 (Fee)
30314U788
30314U804 (Fee)
2 Year
Sabrient Baker's Dozen, 3rd Qtr 2020 ------- 7/20/2020
30314Q845
30314Q860 (Fee)
30314Q852
30314Q878 (Fee)
15 Month
Senior Loan & Limited Duration Closed-End, 96 ------- 7/20/2020
30314X303
30314X329 (Fee)
30314X311
30314X337 (Fee)
2 Year
Limited Duration Fixed Income ETF, 36 ------- 7/21/2020
30314U812
30314U838 (Fee)
30314U820
30314U846 (Fee)
2 Year
Select DSIP, 3rd Qtr 2020 ------- 7/21/2020
30314T468
30314T484 (Fee)
30314T476
30314T492 (Fee)
15 Month
Capital Strength Buy-Write, 52 ------- 7/22/2020
30314U853
30314U861 (Fee)
18 Month
S&P Dividend Aristocrats Buy-Write, 12 ------- 7/22/2020
30314U879
30314U887 (Fee)
18 Month
American Agenda, 14 ------- 7/24/2020
30314X188
30314X204 (Fee)
30314X196
30314X212 (Fee)
2 Year
Deep Value Dividend, 28 ------- 7/24/2020
30314X220
30314X246 (Fee)
30314X238
30314X253 (Fee)
2 Year
Equity Income Select, 66 ------- 7/24/2020
30314X261
30314X287 (Fee)
30314X279
30314X295 (Fee)
2 Year
U.S. Revenue, 18 ------- 7/24/2020
30314X147
30314X162 (Fee)
30314X154
30314X170 (Fee)
2 Year
Cboe Vest Large Cap Buffered, 9 ------- 7/27/2020
30314T864
30314T872 (Fee)
16 Month
Financials Select, 73 ------- 7/28/2020
30314X428
30314X444 (Fee)
30314X436
30314X451 (Fee)
2 Year
New Jersey & New York Municipal Income Select Closed-End, 6 ------- 7/28/2020
30314X667
30314X683 (Fee)
30314X675
30314X691 (Fee)
2 Year
SMid High Dividend, 39 ------- 7/28/2020
30314X469
30314X485 (Fee)
30314X477
30314X493 (Fee)
2 Year
Utilities Select, 56 ------- 7/28/2020
30314X543
30314X568 (Fee)
30314X550
30314X576 (Fee)
2 Year
Precious Metals Select, 45 ------- 7/29/2020
30314X709
30314X725 (Fee)
30314X717
30314X733 (Fee)
2 Year
Health Care Select, 59 ------- 7/31/2020
30314X501
30314X527 (Fee)
30314X519
30314X535 (Fee)
2 Year
Election, 16 ------- 8/5/2020
30314X584
30314X600 (Fee)
30314X592
30314X618 (Fee)
15 Month
Innovative Health Care Portfolio, 5 ------- 8/5/2020
30314X782
30314X808 (Fee)
30314X790
30314X816 (Fee)
15 Month
Preferred Income, 104 ------- 8/5/2020
30314X824
30314X840 (Fee)
30314X832
30314X857 (Fee)
2 Year
Strategic Income Select Closed-End, 46 ------- 8/5/2020
30314Y103
30314Y129 (Fee)
30314Y111
30314Y137 (Fee)
2 Year
Banking Opportunity, 39 ------- 8/7/2020
30314Y145
30314Y160 (Fee)
30314Y152
30314Y178 (Fee)
15 Month
Cloud Computing, 30 ------- 8/7/2020
30314Y186
30314Y202 (Fee)
30314Y194
30314Y210 (Fee)
2 Year
Dividend Strength Opportunity, 14 ------- 8/7/2020
30314Y228
30314Y244 (Fee)
30314Y236
30314Y251 (Fee)
15 Month
Dow® Target 10, August 2020 ------- 8/10/2020
30314U390
30314U416 (Fee)
30314U408
30314U424 (Fee)
13 Month


 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2020 All rights reserved.